©The Author(s) 2025.
World J Gastrointest Oncol. Nov 15, 2025; 17(11): 112981
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.112981
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.112981
Figure 1 Kaplan-Meier analysis for progression-free survival and overall survival in advanced gastric cancer patients receiving immu notherapy combined with chemotherapy.
A: Kaplan-Meier analysis for progression-free survival in advanced gastric cancer patients receiving immunotherapy combined with chemotherapy; B: Kaplan-Meier analysis for overall survival in advanced gastric cancer patients receiving immunotherapy combined with chemotherapy. CI: Confidence interval.
- Citation: Yao ZY, Bao G, Li GC, Hao QL, Ma LJ, Rao YX, Xu K, Ma X, Han ZX. Survival prognosis in advanced HER-2 negative gastric cancer treated with immunochemotherapy: A novel model. World J Gastrointest Oncol 2025; 17(11): 112981
- URL: https://www.wjgnet.com/1948-5204/full/v17/i11/112981.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i11.112981